See more about the project by clicking the buttons below and join our social media for updates about our events:
Dear Colleagues and Friends,
Welcome to the GenE-HumDi COST Action CA21113 2nd International Meeting in Limassol, Cyprus on 8 – 10 April 2024!
Recent breakthroughs in genome editing (GE) technologies have ignited new possibilities for treating diseases by precise and efficient genome modification. Our event will delve into the impressive results already achieved, be it in the creation of new tools, in efficiency and cell selectivity of delivery, in cellular or animal models, and across a wide spectrum of diseases. In our public conference on day 1 and our subsequent CA21113 working group meetings we will address the persisting challenges, which include harmonization of assessments and streamlining of regulatory procedures for novel treatments, translation of findings into treatments and company portfolios, and the development of an entrepreneur mindset in young researchers.
We look forward to welcoming you to Limassol, to move our Action closer to our goal of uniting efforts, increasing resilience and facilitating progress in the European GE sector across pharmaceutical and biotech companies, academic institutions, patient advocacy groups and regulatory bodies. Together, we will accelerate the translation of GE technologies for human disease treatment!
Join us for updates on the latest GE research, technology, and tools, as well as discussions with leading EU stakeholders. Let’s pave the way toward routine clinical application of GE technology, while savoring the sights and flavors of beautiful Cyprus!
With kind regards,
Carsten Werner Lederer & Petros Patsali
Local Organizers